Post-Traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a chronic psychiatric condition that develops following exposure to a traumatic event involving actual or threatened death, serious injury, or sexual violence, characterized by re-experiencing symptoms, avoidance behaviors, negative alterations in cognition and mood, and alterations in arousal and reactivity. PTSD affects approximately 3.5% of the U.S. adult population with a lifetime prevalence of 8%, though rates reach 50% among combat veterans and sexual assault survivors. It is more common in women (approximately 2:1 female-to-male ratio) and typically emerges within 3 months of the traumatic event, though onset can be delayed. The disorder carries significant morbidity including impaired occupational and social functioning, increased suicide risk, and substantial healthcare burden, making recognition and treatment essential for clinical practice. Understanding PTSD pathophysiology and evidence-based interventions is frequently tested on USMLE Step 2 CK, particularly in context of trauma, depression, and anxiety management.

PTSD results from maladaptive neurobiological changes following trauma exposure, involving dysregulation of multiple neurotransmitter systems, altered neural circuits, and persistent threat-related learning. The disease process represents failure of normal psychological processing and extinction of fear-conditioned memories.

Normal traumatic memory processing involves the amygdala (emotional processing center), hippocampus (contextual memory), and prefrontal cortex (PFC) working in concert. Following trauma, the amygdala becomes hyperresponsive to threat-related cues, creating exaggerated fear responses. In PTSD, there is failure to properly extinguish conditioned fear responses—the gradual weakening of fear associations that normally occurs with repeated safe exposures. The dorsolateral prefrontal cortex (dlPFC), which normally inhibits amygdala activity through top-down regulation, shows reduced activation and reduced functional connectivity with the amygdala. The ventromedial prefrontal cortex (vmPFC), critical for fear extinction and emotional regulation, demonstrates structural volume reduction and functional hypoactivity. This neuroanatomical dysregulation prevents the normal transition from acute stress response to resolution, perpetuating the symptom cycle.

The locus coeruleus (LC), the brain's primary noradrenaline production center, becomes chronically overactive in PTSD. Elevated norepinephrine levels enhance amygdala responsiveness and promote threat-related memory encoding, explaining intrusive memories and heightened startle responses. Noradrenergic overflow increases sympathetic nervous system tone, causing hyperarousal symptoms (insomnia, irritability, hypervigilance). This system demonstrates sensitization—progressively lower thresholds for activation in response to trauma reminders. Prazosin, an α1-adrenergic antagonist, reduces nightmares and hyperarousal by dampening LC-mediated noradrenergic tone, providing clinical evidence for this mechanism's role.

The hypothalamic-pituitary-adrenal (HPA) axis, the body's stress response system, paradoxically shows hyporesponsiveness in chronic PTSD despite hypervigilance to threat. Acute trauma triggers normal HPA axis activation (corticotropin-releasing hormone → adrenocorticotropic hormone → cortisol release), but chronic PTSD involves downregulation of glucocorticoid receptors and increased negative feedback sensitivity. This results in lower baseline cortisol levels, blunted cortisol response to acute stress, and enhanced glucocorticoid receptor density. The mechanistic significance is complex: insufficient glucocorticoids fail to appropriately shut down amygdala activity, permitting fear sensitization, while the hyperactive negative feedback prevents appropriate emergency stress responses. Additionally, elevated corticotropin-releasing hormone in the cerebrospinal fluid drives anxious arousal independent of cortisol levels.

γ-Aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter, is reduced in PTSD, particularly in circuits involving the amygdala and anterior cingulate cortex. Diminished GABAergic inhibition permits excessive amygdala firing and reduces the brain's capacity to suppress threat responses. GABA-receptor dysfunction is associated with heightened anxiety and reduced extinction of conditioned fear. Benzodiazepines enhance GABA function but are not first-line treatment due to dependence risks; however, their temporary anxiolytic effects demonstrate the GABAergic deficit's clinical relevance.

Glutamate, the brain's primary excitatory neurotransmitter, becomes dysregulated in PTSD with excessive activity at N-methyl-D-aspartate (NMDA) receptors in fear-processing circuits. Prolonged trauma leads to pathological glutamatergic signaling that strengthens fear memories through long-term potentiation while simultaneously impairing extinction learning. Elevated extracellular glutamate in the prefrontal cortex impairs top-down emotional regulation. Ketamine, an NMDA antagonist, shows rapid anxiolytic effects in some PTSD patients through blockade of this excitotoxic pathway, though its use remains experimental.

The serotonin system, critical for mood regulation and fear extinction, is hypoactive in PTSD. Reduced serotonergic tone in the dorsolateral prefrontal cortex impairs extinction learning and contributes to negative mood symptoms and emotional numbing. Serotonin normally promotes behavioral flexibility and adaptive responses to new information; its deficiency locks patients into threat-oriented cognitive patterns. This mechanism explains why selective serotonin reuptake inhibitors (SSRIs) are first-line pharmacotherapy—they increase serotonin availability to promote extinction and mood recovery.

In PTSD, traumatic memories become fragmented and hyperconsolidated through aberrant protein synthesis, particularly elevated brain-derived neurotrophic factor (BDNF) in amygdala. Traumatic memories become disconnected from contextual information (the hippocampus normally encodes context), causing trauma reminders to trigger full trauma responses regardless of current safety. The normal process of memory reconsolidation (whereby memories become temporarily labile and can be updated when retrieved) is impaired, preventing therapeutic updating through exposure therapy or trauma-focused cognitive behavioral therapy. This explains why traumatic memories feel timeless and intrusive rather than "normal" autobiographical memories.

PTSD develops following exposure to a qualifying traumatic event, but only a minority of trauma-exposed individuals develop the disorder. The interplay between event characteristics, individual vulnerability factors, and post-trauma environmental factors determines risk.

PTSD by definition requires exposure to trauma involving actual or threatened death, serious injury, or sexual violence through direct experience, witnessing, learning of occurrence to close others, or repeated indirect exposure (e.g., first responders). Common traumas include combat exposure, motor vehicle accidents, sexual assault, physical assault, serious accidents, sudden death of close others, life-threatening illness, and childhood abuse. The subjective perception of threat intensity correlates more strongly with PTSD risk than objective event severity; patients with similar objective exposures show variable rates of disorder development.

Pre-existing psychiatric conditions, particularly depression and anxiety disorders, increase PTSD risk 2-3 fold. Family history of PTSD and other psychiatric disorders indicates genetic vulnerability; twin studies demonstrate approximately 30-40% heritability of PTSD. Lower education level, lower socioeconomic status, and younger age at trauma exposure are independent risk factors. Childhood trauma exposure or adverse childhood experiences sensitize neural circuits and increase later PTSD risk through neurobiological "priming" of stress response systems. Female gender carries approximately 2-fold increased risk, potentially reflecting biological (greater amygdala reactivity) and social factors (higher sexual trauma exposure).

High-intensity trauma with perceived threat to life increases PTSD risk substantially; combat exposure shows 15-20% PTSD prevalence while other traumas show 3-8%. Duration and repetition of trauma increase risk; chronic abuse or repeated combat exposure yields higher rates than single-incident trauma. Sexual trauma shows particularly high PTSD rates (approximately 50% in assault survivors) due to intense perceived threat, humiliation, and often interpersonal betrayal. Traumas involving human perpetrators show higher PTSD risk than accidents, possibly due to added dimensions of shame and mistrust. Early trauma age (childhood abuse) and trauma during vulnerable developmental periods increase risk.

Strong social support, family cohesion, and access to early intervention substantially reduce PTSD risk. Conversely, ongoing stress, financial hardship, continued threat (e.g., ongoing domestic violence), and unstable housing increase risk. Cultural factors and community resources influence disorder development; some cultures with stronger collective trauma processing show lower PTSD rates despite similar exposures. Secondary victimization or unsympathetic treatment by authorities worsens prognosis. Lack of access to mental health treatment perpetuates symptoms.

PTSD presents with four symptom clusters: re-experiencing (intrusion), avoidance, negative alterations in cognition and mood (NACM), and alterations in arousal and reactivity (AAR). Symptom onset typically occurs within 3 months but can be delayed. The acute stress disorder (ASD) diagnosis applies if symptoms persist 3 days to 1 month; PTSD requires symptoms persisting beyond 1 month with functional impairment.

Intrusive memories involve involuntary, distressing recall of trauma details, often fragmented and sensory-focused (images, sounds, smells, physical sensations) rather than coherent narrative. These memories feel present-tense, as if the trauma is happening now, reflecting the brain's failure to properly contextualize the memory as past. Nightmares related to trauma content are nearly universal in severe PTSD; patients wake in distress and may avoid sleep. Flashbacks (dissociative experiences where the person feels as though reliving the trauma) represent the most functionally impairing intrusion symptom; during flashbacks, reality orientation may be temporarily lost. Intrusive memories are involuntary and uncontrollable, distinguished from voluntary deliberate recall. These arise from amygdala hyperactivity and failure of top-down prefrontal suppression. Ordinary reminders (trauma-related sights, sounds, smells, anniversaries) trigger intrusive symptoms through amygdala-dependent conditioning, even when the patient is aware the reminder is safe.

Avoidance of trauma-related thoughts, feelings, and reminders is nearly universal and represents an attempt to escape distress but paradoxically perpetuates the disorder by preventing extinction learning. Patients avoid discussing trauma, avoid locations or activities associated with trauma, and avoid trauma-related media or news. Internal avoidance involves suppression of memories and emotions rather than behavioral avoidance; suppression is often ineffective and may exacerbate symptoms through rebound intrusions. Avoidance provides temporary relief but prevents the neural circuits from learning that reminders are safe, maintaining threat perception. Functional impairment follows naturally as patients increasingly limit their activities; avoidance of places may lead to agoraphobic-like restriction; avoidance of people related to trauma may isolate patients.

Emotional numbing or blunted affect reflects reduced amygdala-to-prefrontal connectivity and opioid system dysregulation; patients feel disconnected from emotional experiences and others. Persistent negative self-beliefs ("I am bad," "I am damaged," "I am to blame") arise from trauma disrupting prior schemas and represent maladaptive meaning-making. Excessive blame of self or others is common; sexual assault survivors frequently exhibit self-blame reflecting societal stigma internalization. Persistent negative expectations ("The world is entirely dangerous," "I cannot trust anyone") reflect overgeneralization of threat from the specific trauma. Diminished interest in activities (anhedonia) and social withdrawal occur alongside mood disturbance. Depressive symptoms are nearly universal with chronic PTSD; distinguishing primary mood disorder from PTSD-related depression can be challenging but the depression typically emerges after trauma rather than preceding it. Difficulty remembering important aspects of the trauma reflects disruption of hippocampal encoding during traumatic stress due to amygdala dominance, resulting in fragmented memories of peripheral details with loss of narrative coherence.

Hypervigilance reflects persistent threat-scanning mediated by amygdala hyperactivity; patients constantly monitor surroundings for danger and may appear "on edge." Hypervigilance is exhausting and contributes to insomnia and fatigue. Exaggerated startle response (jumping at unexpected sounds) occurs in approximately 80% of PTSD patients and reflects sensitized locus coeruleus-amygdala circuits; families often report the patient startles dramatically at minor stimuli. Reckless or self-destructive behavior may emerge, representing either emotion-regulation attempts (risk-taking as distraction) or loss of concern for personal safety from demoralization. Sleep disturbance is nearly universal; nightmares directly disrupt sleep, while hyperarousal causes insomnia with difficulty initiating and maintaining sleep. Irritability and aggression emerge from prefrontal hypoactivity and amygdala dominance; patients have low frustration tolerance and may have verbal or physical outbursts disproportionate to triggers, often directed at loved ones. Difficulty concentrating reflects divided attention as the threat-detection system consumes cognitive resources; patients report "brain fog" and inability to focus on work or conversation. Reckless behavior includes substance abuse (self-medication for symptoms), high-risk sexual behavior, or unsafe driving; substance use disorder develops in approximately 10-20% of PTSD patients.

Physical examination may reveal signs of anxiety or trauma: tremor, tachycardia, tachypnea, and elevated blood pressure reflecting sympathetic hyperactivity. Patients may appear anxious or guarded during interview. Startle response can be formally assessed and quantified. Many PTSD patients demonstrate hypervigilance observable as constant monitoring of exits, positioning away from doorways, or difficulty relaxing. Self-inflicted scars or marks may indicate non-suicidal self-injury used for affect regulation. Restricted affect or flat affect may be notable, particularly in chronic cases.

Complex PTSD (C-PTSD), recognized in the ICD-11 but not DSM-5, develops following prolonged, repeated trauma, particularly during childhood (childhood abuse, domestic violence). Complex PTSD includes standard PTSD symptoms plus severe disturbances in self-perception (pervasive shame, guilt, self-blame), difficulties in relationship formation and trust, and problems modulating emotional responses. Delayed-onset PTSD occurs when symptom onset is more than 3 months after trauma; this typically reflects either minimization initially followed by triggering events, or trauma repercussions that only become apparent over time.

PTSD diagnosis relies on clinical interview capturing trauma history and symptom clustering per DSM-5 criteria. No laboratory tests or imaging studies are diagnostically sufficient, though objective measures can support assessment and track treatment response.

Diagnosis requires: (1) Criterion A: Exposure to actual or threatened death, serious injury, or sexual violence through direct experience, witnessing, learning of occurrence to close others, or repeated indirect exposure; (2) Criterion B: Presence of at least one intrusion symptom (involuntary memories, nightmares, flashbacks, psychological or physiological reactivity to reminders); (3) Criterion C: At least one avoidance symptom (avoidance of reminders through thoughts, conversations, places, people, or activities); (4) Criterion D: Negative alterations in cognition and mood with at least two symptoms from categories including negative beliefs, blame attributions, persistent negative affect, diminished interest in activities, feeling detached from others, or inability to remember important trauma aspects; (5) Criterion E: Alterations in arousal and reactivity with at least two symptoms including irritability/aggression, recklessness, hypervigilance, exaggerated startle, difficulty concentrating, or sleep disturbance; (6) Criterion F: Symptom duration at least 1 month; (7) Criterion G: Functional impairment in social, occupational, or other important domains; (8) Criterion H: Disturbance not attributable to substance use or medical conditions. Diagnosis requires symptom presence from all four clusters, with specific minimum symptom counts (generally 6 of 20 possible symptoms).

The clinical history should systematically explore trauma exposure type, intensity, proximity, and timing. Open-ended questions ("Tell me about the most traumatic or frightening experience you've had") often yield better information than direct questioning. Assess specific symptoms from each criterion cluster: ask about nightmares and intrusive thoughts, avoidance patterns, changes in worldview and self-